Caplight Logo









Sarcura

Sarcura

Private
KlosterneuburgHealthcare & Life Scienceshttps://sarcura.com

Last Round

Grant

Mar 5, 2024

Total Funding Raised

$13.92M

Momentum Score

50 /100

Company Overview

Sarcura is a biotech company that develops a machine platform for the large-scale, industrial manufacturing of personalized cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Smart Manufacturing, Semiconductors, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

cell therapy manufacturingcell therapy automationCAR-T manufacturingmicrofluidicssilicon photonicslab-on-a-chipCGT manufacturingphotonic cell sortingautonomous manufacturingminiaturized manufacturingcell sortingautomated bioprocessingmicrofluidic cartridgescell therapy factory in a boxdecentralized manufacturingreal-time quality controlpoint-of-care manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sarcura Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sarcura Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMar 5, 2024
GrantJun 1, 2023
SeedNov 17, 2022
GrantMar 1, 2021
SeedNov 19, 2020

Key People

Founding team and executive leadership

Erwin Gorjup

Chief Scientific Officer & Co-Founder

Founding Team

Daniela Buchmayr

CEO Co-Founder

Founding Team

Sarcura Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2025

    Won the LLB Banking Österreich zukunft award 2025.

Sarcura Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sarcura Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sarcura's valuation, stock price, and market status.

Firmographic Details

HeadquartersKlosterneuburg
Employee Range11
Year Founded2019
Last FundingMar 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.